COVID 19 and Psychological Health: a Cross Sectional Study to Evaluate Anxiety and Depression in Covid-19 Patients
NCT ID: NCT04689464
Last Updated: 2021-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
450 participants
OBSERVATIONAL
2020-12-01
2021-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To answer these questions, a survey made to the hospitalized patients including sex, age, educational level, Marital state, and a standardized questionnaires (GAD-7 and PHQ-9) which has been validated and shown to possess good psychometric qualities in studies of participants from multiple populations.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Mental Health in Healthcare Workers Exposed to COVID-19 Patients
NCT04473118
COVID-19 : Stress Within Hospital Workers
NCT05037214
Effects of Breathing Exercises on Fear of COVID-19, Anxiety, Sleep and Quality of Life During the COVID-19 Pandemic
NCT04910932
Psychological Impairment Due to Covid-19
NCT04368312
Impact of SARS-CoV-2 Pandemic on Psychological State of Health Care Workers
NCT04779944
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
mild covid
No interventions assigned to this group
moderate covid
No interventions assigned to this group
severe covid
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Basrah
OTHER
Ministry of Health, Iraq
NETWORK
Alhasan Mujtaba Al-Mudhaffer
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alhasan Mujtaba Al-Mudhaffer
Clinical Pharmacy Specialist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zainab N Abdul-nabi, M.Sc.
Role: STUDY_DIRECTOR
University of Basrah
Hiba Dawood, M.Sc.
Role: STUDY_DIRECTOR
University of Basrah
Qussay N Almaliki, Ph.D.
Role: STUDY_DIRECTOR
AlFayhaa teaching hospital
Nadheera F Neamah
Role: STUDY_DIRECTOR
University of Basrah
Dania Zydoon
Role: PRINCIPAL_INVESTIGATOR
Al-Sader teaching hospital
Zainab Mahdi
Role: PRINCIPAL_INVESTIGATOR
Al-Mawani general hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AlFayhaa Teaching hospital
Basra, , Iraq
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1120
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.